Li Diandian, Liu Lian, Qin Jiangyue, Shen Cheng, Wang Bo
Department of Respiratory and Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, 610041, Sichuan, China.
State Key Laboratory of Respiratory Health and Multimorbidity, Sichuan University, Chengdu, 610041, Sichuan, China.
Lung. 2025 Jun 4;203(1):67. doi: 10.1007/s00408-025-00821-7.
Pyruvate kinase M2 (PKM2) is a critical enzyme regulating cell metabolism and growth under different physiological conditions. In its metabolic role, PKM2 catalyzes the final and also a rate-limiting reaction in the glycolytic pathway, converting phosphoenolpyruvate (PEP) to pyruvate while phosphorylating adenosine diphosphate (ADP) to pyruvate and adenosine-triphosphate (ATP). Also, PKM2 has been reported to function as a protein kinase that regulates gene transcription and expression involved in cellular growth and survival. Current studies have focused on the glycolytic and non‑glycolytic functions of PKM2 in various tissues and organs. In this review, we summarize the in-depth role of PKM2 in the pathogenesis in pulmonary diseases including chronic obstructive pulmonary disease (COPD), asthma, pulmonary arterial hypertension (PAH), acute lung injury (ALI), pulmonary fibrosis, infectious lung disease and lung cancer. We also discuss its potential applications in disease diagnosis and therapies.
丙酮酸激酶M2(PKM2)是一种在不同生理条件下调节细胞代谢和生长的关键酶。在其代谢作用中,PKM2催化糖酵解途径中的最后一步也是限速反应,将磷酸烯醇式丙酮酸(PEP)转化为丙酮酸,同时将二磷酸腺苷(ADP)磷酸化为三磷酸腺苷(ATP)。此外,据报道PKM2还可作为一种蛋白激酶,调节参与细胞生长和存活的基因转录和表达。目前的研究集中在PKM2在各种组织和器官中的糖酵解和非糖酵解功能。在这篇综述中,我们总结了PKM2在包括慢性阻塞性肺疾病(COPD)、哮喘、肺动脉高压(PAH)、急性肺损伤(ALI)、肺纤维化、感染性肺病和肺癌在内的肺部疾病发病机制中的深入作用。我们还讨论了其在疾病诊断和治疗中的潜在应用。